It started as a simple work injury and became an aggressive cancer, now Mark Depledge has undergone seven surgeries and lost his right hand. The 57-year-old carpenter noticed his hand wasn’t ...

The final, formatted version of the article will be published soon. This case report illustrates an uncommon presentation of incomplete intestinal obstruction, characterized by abdominal distension ...

Myxofibrosarcoma (MFS) is an exceedingly rare malignant neoplasm of fibroblastic origin, characterized by its low clinical incidence. It primarily manifests in the extremities and the posterior trunk, ...

Primary intracranial myxofibrosarcoma is exceedingly rare, with less than 10 cases published. We present a case of a 23-year-old man with previous history of a primary low grade myxofibrosarcoma of ...

ABSTRACT: Introduction: Primary cardiac myxofibrosarcoma (MFS) is a rare and aggressive malignancy, with limited treatment options and a high recurrence rate. Multimodal imaging is critical for ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

ABSTRACT: Soft tissue sarcomas represent only 1% of all adult cancers; myxofibrosarcoma is the most common type that arises in adult extremities, particularly lower limbs (77%), other less common ...

Among patients with unresectable or metastatic undifferentiated pleomorphic sarcoma or myxofibrosarcoma, envafolimab generated positive efficacy data with a well-tolerated safety profile. Single-agent ...

Myxofibrosarcoma is a malignant mesenchymal tumor and a fibroblastic sarcoma of the elderly. Myxofibrosarcoma can be low-grade or high-grade depending on the cell characteristics. Wide surgical ...

: This retrospective study included 54 patients. The tumors were classified into high-grade and low-grade myxofibrosarcoma. The tumor size, signal intensity heterogeneity, margin, and surrounding ...